Prior to the COVID-19 pandemic, that more than 60% of US adults were lonely; these numbers only increased during the pandemic. Clinicians should focus more time on the psychological and social factors of aging to improve the quality of life of the elderly.
Lower exacerbation counts, fewer health care encounters for asthma symptoms seen in asthma patients with T2D initiating GLP-1R agonists
Calciphylaxis treatment should include a multimodal approach with a focus on supportive care, infection prevention, pain management, and wound healing.
The researchers evaluated the prevalence and risk factors for depressive symptoms in patients with diabetes using data from an international study to glean information about people in developing countries.
The effects of hybrid comprehensive telerehabilitation compared with usual care were analyzed in a cohort of patients with HFrEF.
Sixty-nine of 78 participants with type 2 diabetes on treatment for hypertension stopped all or some antihypertensive and diuretic medications.
Icodec results in greater increase in time-in-range versus once-daily insulin glargine U100 in two phase 2 randomized, open-label trials
Man with a 10-year history of type 2 diabetes presents with new symptoms of proximal muscle weakness and profound fatigue. Could he have a secondary cause of diabetes?
Diabetes is one of the most expensive chronic diseases, yet few patients discuss cost-of-treatment with their primary care physicians.
The ProDiGY consortium examined the effect of known genetic variants associated with T2D on adults with youth-onset diabetes.
Greater variability in systolic blood pressure and diastolic blood pressure was associated with increased CVD mortality risk in T2D.
Opioids were prescribed to nearly 43% of patients newly diagnosed with diabetic peripheral neuropathy who were started on pain medications.
At follow-up, 65.9% of the treatment group and 8.5% of the control cohort exhibited improvements in painful diabetic neuropathy.
Black race, Asian race, and female gender were associated with lower rates of SGLT2 inhibitor use in patients with type 2 diabetes.
SGLT2i use was linked to reduced mortality and morbidity in a real-world cohort of patients with heart failure and diabetes.
Patients with type 1 and type 2 diabetes have a high risk of cardiovascular disease (CVD), but now, a new study shows that type 1 diabetes patients are more susceptible to both cardiovascular and renal disease.
Intensive lifestyle intervention may increase the risk for cardiovascular disease for type 2 diabetes patients with overweight or obesity and poor glucose control.
Type 2 diabetes mellitus (T2DM) is associated with an increased risk for Parkinson disease (PD), as well as more rapid PD progression.
The researchers’ aim was to quantify shoulder disorders using physical exam and ultrasound imaging in patients with both type 2 diabetes and shoulder pain.
Vitamin D supplementation is associated with a 13% decrease in progression to diabetes in patients with prediabetes.